Pablo C Okhuysen MD
HIV/AIDS Medicine, Transplant/Immunocompromised States, International Health, Travel & Tropical
Professor, Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX
Join to View Full Profile
The University of Texas MD Anderson Cancer Center1515 Holcombe, Unit 1460Houston, TX 77030
Phone+1 713-745-8413
Fax+1 713-745-6839
Dr. Okhuysen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Pablo Okhuysen is an infectious disease specialist based in Houston, TX, with subspecialties in HIV/AIDS medicine, transplant/immunocompromised states, international health, and travel and tropical medicine. He completed his medical education at Universidad Autonoma de Guadalajara, followed by an internship at Cook County Health and Hospitals System, and residency and fellowship at the University of Texas Health Science Center at Houston. Currently, he serves as a professor at the University of Texas M.D. Anderson Cancer Center. Dr. Okhuysen has co-authored various publications focused on infections and microbiomes in cancer patients and has been involved in clinical trials on diarrhea prophylaxis and Clostridium difficile infection treatments.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 1991 - 1994- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1989 - 1991
Cook County Health and Hospitals SystemInternship, Internal Medicine, 1988 - 1989
Universidad Autonoma de GuadalajaraClass of 1988
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2028
GA State Medical License 2023 - 2027
TN State Medical License 2023 - 2027
AL State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
MS State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise E HR, Allscripts, 2012, 2015
Clinical Trials
- An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection Start of enrollment: 2019 Aug 02
- Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy Start of enrollment: 2020 Oct 07
Publications & Presentations
PubMed
- 1 citationsBezlotoxumab for the prevention of recurrentinfection for patients with cancer.Jaime A Peña, Cyril B Mazhuvanchery, Maria Julia Moura Nascimento Santos, Sidra Naz, Carolina Colli Cruz
Annals of Gastroenterology. 2025-08-14 - 1 citationsGastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis.Malek Shatila, Kian Abdul-Baki, Andres Urias Rivera, Kei Takigawa, Irene Jeong-Ah Lee
Cancer Medicine. 2025-08-01 - Ten Practical Tips for a Successful Presentation at an Infectious Disease Clinical Case Conference.Takahiro Matsuo, Pablo C Okhuysen, Ben J Barnett
Open Forum Infectious Diseases. 2025-07-01
Press Mentions
Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)December 12th, 2024- Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)November 4th, 2024
- Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)November 4th, 2024
Grant Support
- Gene Polymorphisms Predisposing To Infectious DiarrheaNational Institute Of Allergy And Infectious Diseases2003–2007
- IL-2 (PROLEUKIN) In HIV+ Patients In A Randomized International Trial (ESPRIT)National Center For Research Resources2005
- Comparison Of The Clinical Consequences Of Two Anti-Retroviral Regimens In HIVNational Center For Research Resources2005
- Ucrc Special Case Study ProtocolNational Center For Research Resources2004–2005
- Infectivity Of Cryptosporidium Parvum For Adult HumansNational Center For Research Resources1998–2005
Professional Memberships
- Member
- Fellow
- Member
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
